S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
Log in
NASDAQ:CUTR

Cutera Stock Forecast, Price & News

$35.32
-0.40 (-1.12 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$34.56
Now: $35.32
$36.57
50-Day Range
$22.61
MA: $28.81
$37.46
52-Week Range
$9.07
Now: $35.32
$38.80
Volume100,642 shs
Average Volume146,386 shs
Market Capitalization$622.80 million
P/E RatioN/A
Dividend YieldN/A
Beta1.6
Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide. The company offers truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; truSculpt for the non-surgical body sculpting market; Juliet, a laser for women's intimate health; Secret RF, a fractional radio frequency microneedling device for skin revitalization; and enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions and acne scars. It also provides excel HR platform, a hair removal solution for various skin types; excel V+, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus, CoolGlide, and myQ products. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website cutera.com. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1988 and is headquartered in Brisbane, California.
Cutera logo

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
Current SymbolNASDAQ:CUTR
CUSIPN/A
Phone415-657-5500
Employees447
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$181.71 million
Book Value$3.23 per share

Profitability

Net Income$-12,350,000.00

Miscellaneous

Market Cap$622.80 million
Next Earnings Date5/6/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.25 out of 5 stars

Computer And Technology Sector

501st out of 1,523 stocks

Electromedical Equipment Industry

19th out of 61 stocks

Analyst Opinion: 1.4Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
$35.32
-0.40 (-1.12 %)
(As of 02/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CUTR News and Ratings via Email

Sign-up to receive the latest news and ratings for CUTR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cutera (NASDAQ:CUTR) Frequently Asked Questions

Is Cutera a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Cutera stock.
View analyst ratings for Cutera
or view top-rated stocks.

What stocks does MarketBeat like better than Cutera?

Wall Street analysts have given Cutera a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cutera wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Cutera's next earnings date?

Cutera is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Cutera
.

How were Cutera's earnings last quarter?

Cutera, Inc. (NASDAQ:CUTR) released its earnings results on Tuesday, February, 16th. The medical device company reported $0.31 EPS for the quarter, topping analysts' consensus estimates of ($0.11) by $0.42. Cutera had a negative trailing twelve-month return on equity of 61.21% and a negative net margin of 18.83%.
View Cutera's earnings history
.

How has Cutera's stock price been impacted by Coronavirus?

Cutera's stock was trading at $18.11 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CUTR stock has increased by 95.0% and is now trading at $35.32.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for CUTR?

4 brokers have issued 12 month price targets for Cutera's shares. Their forecasts range from $24.00 to $38.00. On average, they anticipate Cutera's share price to reach $29.33 in the next twelve months. This suggests that the stock has a possible downside of 16.9%.
View analysts' price targets for Cutera
or view top-rated stocks among Wall Street analysts.

Who are Cutera's key executives?

Cutera's management team includes the following people:
  • Mr. David H. Mowry, CEO & Director (Age 59, Pay $751.41k)
  • Mr. R. Jason Richey, Pres (Age 47, Pay $1.02M)
  • Mr. Rohan Seth, Chief Financial Officer
  • Dr. Michael Karavitis, Exec. VP & Chief Technology Officer
  • Mr. Matthew Scalo, VP of Investor Relations & Corp. Devel.
  • Tanya Rodante, Director of Corp. Communications
  • Mr. Rajesh Madan, VP of Fin.

What is David H. Mowry's approval rating as Cutera's CEO?

1 employees have rated Cutera CEO David H. Mowry on Glassdoor.com. David H. Mowry has an approval rating of 100% among Cutera's employees. This puts David H. Mowry in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Cutera's key competitors?

What other stocks do shareholders of Cutera own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include NVIDIA (NVDA), QUALCOMM (QCOM), AbbVie (ABBV), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), DocuSign (DOCU), Pfizer (PFE), Square (SQ) and Twilio (TWLO).

What is Cutera's stock symbol?

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

Who are Cutera's major shareholders?

Cutera's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.08%), Victory Capital Management Inc. (8.95%), Gamco Investors INC. ET AL (7.59%), Gabelli Funds LLC (3.50%), Royce & Associates LP (3.08%) and Renaissance Technologies LLC (3.01%). Company insiders that own Cutera stock include David H Mowry, J Daniel Plants and Katherine S Zanotti.
View institutional ownership trends for Cutera
.

Which major investors are selling Cutera stock?

CUTR stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., JPMorgan Chase & Co., The Manufacturers Life Insurance Company , ExodusPoint Capital Management LP, Renaissance Technologies LLC, Gabelli Funds LLC, Teton Advisors Inc., and Dimensional Fund Advisors LP.
View insider buying and selling activity for Cutera
or view top insider-selling stocks.

Which major investors are buying Cutera stock?

CUTR stock was bought by a variety of institutional investors in the last quarter, including Royce & Associates LP, Gamco Investors INC. ET AL, BlackRock Inc., Victory Capital Management Inc., Healthcare of Ontario Pension Plan Trust Fund, Stifel Financial Corp, Essex Investment Management Co. LLC, and Calamos Advisors LLC. Company insiders that have bought Cutera stock in the last two years include David H Mowry, J Daniel Plants, and Katherine S Zanotti.
View insider buying and selling activity for Cutera
or or view top insider-buying stocks.

How do I buy shares of Cutera?

Shares of CUTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cutera's stock price today?

One share of CUTR stock can currently be purchased for approximately $35.32.

How much money does Cutera make?

Cutera has a market capitalization of $622.80 million and generates $181.71 million in revenue each year. The medical device company earns $-12,350,000.00 in net income (profit) each year or ($0.88) on an earnings per share basis.

How many employees does Cutera have?

Cutera employs 447 workers across the globe.

What is Cutera's official website?

The official website for Cutera is www.cutera.com.

Where are Cutera's headquarters?

Cutera is headquartered at 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005.

How can I contact Cutera?

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The medical device company can be reached via phone at 415-657-5500 or via email at [email protected]


This page was last updated on 2/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.